Norvir
- Product NDC
- 50090-1162
- 11-digit product format
- 500901162
- Labeler code
- 50090
- Product ID
- 50090-1162_54eb1678-e698-4ceb-bd90-b5d196d45ede
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ritonavir
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- NDA022417
- Marketing category
- NDA
- Marketing start
- 2010-05-06
- Marketing end
- 0000-00-00
- Substance
- RITONAVIR
- Active strength
- 100 mg/1
- Pharmacologic classes
- HIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],UDP Glucuronosyltransferases Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record